Symptomtext
patient was given a dose of PENTACEL today and the vaccine expired on 31Jan2023,with no reported adverse event; Initial information received on 03-Mar-2023 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves a 4 months old female patient who was given a dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] today and the vaccine expired on 31jan2023,with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Prophylactic vaccination. On 03-Mar-2023, the patient received dose 2 at 0.5ml total of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE Suspension for injection (strength: standard) (lot number: UJ658AAA, expiry date: 31-Jan-2023) via unknown route in unknown administration site for Immunization and on the same day, patient was given a dose of pentacel today and the vaccine expired on 31jan2023,with no reported adverse event (expired product administered). It was reported, reporter stated that she is the manager in the office. Caller states that she is calling about PENTACEL and the expiration date. Caller asking if the company has any information regarding this. No further information provided by the reporter. Action taken with DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE (PENTACEL (VERO)) was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.